Literature DB >> 2672017

BCG in the treatment of bladder cancer: state of the art.

A Morales1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2672017

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN： 0361-7742


× No keyword cloud information.
  2 in total

1.  Mixed low- and high-grade non-muscle-invasive bladder cancer: a histological subtype with favorable outcome.

Authors:  Tina Schubert; Matthew R Danzig; Srinath Kotamarti; Rashed A Ghandour; Danny Lascano; Byron P Dubow; G Joel Decastro; Mitchell C Benson; James M McKiernan
Journal:  World J Urol       Date:  2014-08-23       Impact factor: 4.226

2.  Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancer.

Authors:  E C De Boer; W H De Jong; P A Steerenberg; L A Aarden; E Tetteroo; E R De Groot; A P Van der Meijden; P D Vegt; F M Debruyne; E J Ruitenberg
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.